CTT Pharmaceutical Holdings, Inc. (CTTH) stock
CTTHOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2015, quarter ended Sep 30, 2015Last filing: 10-Q on Nov 18, 2026
$0.06−0.00 (-0.17%)
Close on Oct 16, 2026Market cap $1.26MP/E –Yield –
CTT Pharmaceutical revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
No revenue figures for CTT Pharmaceutical
CTT Pharmaceutical has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?